阿西米尼布的使用突出了潜在的莫亚莫亚疾病:一个病例报告
Saloni Savani1, Arpita Pawa1, Naved Salim2
1Internal Medicine, Willis-Knighton Health System, Shreveport, USA.
Cureus
|July 30, 2024
概括
一名患有慢性髓性白血病 (CML) 的患者在开始阿斯基米尼布治疗后发展了莫亚莫亚综合征. 停止服用药物后症状有所改善,这表明存在潜在的联系,需要谨慎.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 莫亚莫亚病 (MMD) 是一种罕见的脑血管疾病,其特点是内动脉的渐进性狭窄.
- 慢性骨髓性白血病 (CML) 是一种骨髓扩散性瘤,通常用氨酸激酶抑制剂治疗.
- 阿西米尼布是一种向BCR-ABL1的全抑制剂,已被批准用于CML治疗,特别是在T315I突变患者中.
研究的目的:
- 报告一种罕见的莫亚莫亚综合征病例,该病例发生在用阿斯基米尼布治疗的CML患者身上.
- 为了突出阿西米尼布和脑血管事件之间的潜在,尽管未经证实的联系.
- 强调在阿西米尼布治疗期间对神经系统副作用的警的重要性.
主要方法:
- 一个40岁的女性患有CML和T315I突变的病例报告.
- 患者开始接受阿西米尼布治疗时呈现出表达性失言症.
- 诊断工作包括脑MRI和CT血管图,揭示了莫亚莫亚综合征.
主要成果:
- 患者在开始服用阿西米尼布治疗一个月后出现表达性失言症.
- 脑部成像显示内动脉和脑动脉的狭窄,与莫亚莫亚综合征相一致.
- 停用阿斯基米尼布导致失言症的症状有所改善.
结论:
- 这一案例表明阿斯基米尼布与莫亚莫亚综合征的发展之间可能存在关联,尽管之前没有关于这种心血管副作用的报道.
- 医生在开阿斯基米尼布的处方时应谨慎,特别是在有中风病史或其他脑血管风险因素的患者中.
- 需要进一步的研究,以调查在CML患者中与阿司明尼布治疗相关的潜在神经风险.
更多相关视频
06:54A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
2.7K
05:19A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
427
相关概念视频
01:25Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
01:26Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
01:21Rheumatic Heart Disease III: Medical Management
544
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
01:30Coronary Artery Disease III: Clinical Manifestations
620
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589